This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of biologically active molecules, often targeting central nervous system disorders. Its ethanesulfonyl and phenylmethanamine groups make it valuable for designing compounds with potential therapeutic effects, such as antidepressants or antipsychotics. Additionally, it may be employed in the development of enzyme inhibitors or receptor modulators due to its structural properties. Its hydrochloride form enhances solubility, making it suitable for various experimental and formulation processes in drug discovery.